Tarbox Family Office’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-48
Closed -$7K 300
2022
Q1
$7K Hold
48
﹤0.01% 434
2021
Q4
$7K Hold
48
﹤0.01% 513
2021
Q3
$6K Hold
48
﹤0.01% 588
2021
Q2
$7K Hold
48
﹤0.01% 540
2021
Q1
$6K Hold
48
﹤0.01% 503
2020
Q4
$5K Hold
48
﹤0.01% 512
2020
Q3
$4K Hold
48
﹤0.01% 518
2020
Q2
$3K Hold
48
﹤0.01% 600
2020
Q1
$3K Buy
48
+33
+220% +$3.04K ﹤0.01% 516
2019
Q4
$2K Hold
15
﹤0.01% 780
2019
Q3
$1K Hold
15
﹤0.01% 888
2019
Q2
$1K Buy
+15
New +$1.23K ﹤0.01% 916

Other funds holding CNMD

Tarbox Family Office's CNMD Position: Q2 2022 in Review

Tarbox Family Office sold out of CONMED (CNMD) in Q2 2022, closing a stake of 48 shares — an estimated $7K sold.

Tarbox Family Office first reported a position in CNMD in Q2 2019 and held it in 12 quarters. The position peaked at $7K in Q1 2022. 280 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

  • Tarbox Family Office reported no remaining CONMED position as of Q2 2022 after selling out during the quarter.
  • Tarbox Family Office sold 48 CONMED shares in Q2 2022, an estimated $7K.
  • Tarbox Family Office first reported a position in CONMED in Q2 2019 and held it in 12 quarters.
  • Tarbox Family Office's CONMED position peaked at $7K in Q1 2022.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.